The Rationale for Immunotherapy in NSCLC

Publication
Article
Special ReportsImmunotherapy (Issue 5)
Volume 5
Issue 1

Heather Wakelee, MD, associate professor of medicine, oncology division, Stanford University, discusses the rationale for immunotherapy in non-small cell lung cancer (NSCLC).

Heather Wakelee, MD, associate professor of medicine, oncology division, Stanford University, discusses the rationale for immunotherapy in non-small cell lung cancer (NSCLC).

<<<

View the entire Special Report on Immunotherapy

Related Videos
Related Content